Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Hypertension and NAT2[original query] |
---|
Risk factor for clear cell renal cell carcinoma in Chinese population: a case-control study. Cancer epidemiology 2012 Apr 36 (2): 177-82. Wang Guoping, Hou Jianguo, Ma Liye, Xie Jiaxin, Yin Jianhua, Xu Danfeng, Chang Wenjun, Tan Xiaojie, Su Tong, Zhang Hongwei, Cao Guangw |
Xenobiotic metabolizing gene variants and renal cell cancer: a multicenter study. Frontiers in oncology 2012 2 16. Heck Julia E, Moore Lee E, Lee Yuan-Chin A, McKay James D, Hung Rayjean J, Karami Sara, Gaborieau Valérie, Szeszenia-Dabrowska Neonila, Zaridze David G, Mukeriya Anush, Mates Dana, Foretova Lenka, Janout Vladimir, Kollárová Helena, Bencko Vladimir, Rothman Nathaniel, Brennan Paul, Chow Wong-Ho, Boffetta Pao |
Different phenotypes of the NAT2 gene influences hydralazine antihypertensive response in patients with resistant hypertension. Pharmacogenomics 2014 Feb 15 (2): 169-78. Spinasse Lizania Borges, Santos Adalberto Rezende, Suffys Philip Noel, Muxfeldt Elizabeth Silaid, Salles Gil Fernan |
Correlation between NAT2 gene polymorphism and cirrhotic portal hypertension in the Chinese population. Genetic testing and molecular biomarkers 2015 Mar 19 (3): 138-43. Li Xiao-Pei, Liu Ying, Zhang Chun-Qi |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: